Buy Native Instruments May 2026

The company reportedly accrued cumulative losses of €288 million ($339 million) across 2023 and 2024. This is largely attributed to debt "pushed down" onto the company after its leveraged buyout by Francisco Partners in 2021.

NI filed for preliminary insolvency in Berlin in late January 2026. As of March 2026, the company confirmed it is transitioning into formal insolvency proceedings for its German non-operating holding companies as part of a planned restructuring.

An attempt by Francisco Partners to sell NI to two private equity firms, Bang Capital and Bridgeport Holdings , was approved in November 2025 but ultimately collapsed, precipitating the insolvency filing. Operational Impact for Buyers

Native Instruments (NI) is currently navigating a high-stakes financial restructuring following a filing for in January 2026. While standard operations continue, the company is actively seeking a new owner or merger partner to resolve significant debt issues stemming from its private equity history. Current Financial and Ownership Status

Report: Native Instruments Market Status and Strategic Outlook (April 2026)

Suggested by Cory

Editorial

10.4244/EIJ-E-26-00001 Mar 2, 2026
Privileged witnesses: how interventional cardiologists can validate experimental evidence in practice
Escaned J and de Waard G
free

Editorial

10.4244/EIJ-D-26-00106 Mar 2, 2026
Getting lost – and found – in revascularising chronic limb-threatening ischaemia
Musialek P and Micari A
free

Viewpoint

10.4244/EIJ-D-25-00807 Mar 2, 2026
Excimer laser coronary atherectomy in contemporary PCI
Jurado-Román A and Basile M
free

Original Research

10.4244/EIJ-D-25-01092 Mar 2, 2026
Intravascular imaging-guided percutaneous coronary intervention in patients with acute coronary syndrome
Takegawa K et al

Original Research

10.4244/EIJ-D-25-00769 Mar 2, 2026
Safety and effectiveness of drug-coated devices in chronic limb-threatening ischaemia: a nationwide analysis
Dubosq-Lebaz M et al
buy native instruments X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved